InnoCare Pharma Ltd Sustainability Reports
InnoCare Pharma Limited is a commercial-stage biopharmaceutical company that discovers, develops, and commercializes innovative drugs for cancer and autoimmune diseases. The company operates primarily across China and global markets with a diverse molecular pipeline.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
LEI: 3003001NYJPPWIEOJT79
FIGI: BBG00S9VV4S7
14 reports from 2019 to 2025
